Cargando…

Individual cognitive changes in subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease using the reliable change index methodology

OBJECTIVE: The development of Alzheimer’s disease (AD) can be assessed using the neuropsychological test battery Vienna (NTBV). The objective of this study was to investigate whether the NTBV test scores of a diagnostic group have changed significantly over time and whether this change is due to dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosas, Anna Garcia, Stögmann, Elisabeth, Lehrner, Johann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2020
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500870/ https://www.ncbi.nlm.nih.gov/pubmed/33095320 http://dx.doi.org/10.1007/s00508-020-01755-1

Ejemplares similares

Differences regarding the five-factor personality model in patients with subjective cognitive decline and mild cognitive impairment
por: Berger-Sieczkowski, Evelyn, et al.
Publicado: (2018)

No effect of thyroid hormones on 5‐year mortality in patients with subjective cognitive decline, mild cognitive disorder, and Alzheimer’s disease
por: Đapić, Blaž, et al.
Publicado: (2022)

Visuoconstructional Abilities of Patients With Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer’s Disease
por: Knechtl, Paula, et al.
Publicado: (2023)

Assessing visuo-constructive functions in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease with the Vienna Visuo-Constructional Test 3.0 (VVT 3.0)
por: Valencia, Noel, et al.
Publicado: (2021)

Self-reported and informant-reported memory functioning and awareness in patients with mild cognitive impairment and Alzheimer´s disease
por: Silva, Martina Rios, et al.
Publicado: (2016)

Individual cognitive change after DBS-surgery in Parkinson’s disease patients using Reliable Change Index Methodology
por: Foki, Thomas, et al.
Publicado: (2018)

From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution
por: Cheng, Yu-Wen, et al.
Publicado: (2017)

Functional Connectivity Changes Across the Spectrum of Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment and Alzheimer’s Disease
por: Wang, Ziqi, et al.
Publicado: (2019)

Anatomical and functional changes in the retina in patients with Alzheimer’s disease and mild cognitive impairment
por: Szegedi, Stephan, et al.
Publicado: (2020)

Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
por: Eliassen, Carl F., et al.
Publicado: (2017)

Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline
por: Ismail, Zahinoor, et al.
Publicado: (2021)

Microstructural brain changes track cognitive decline in mild cognitive impairment
por: Reas, Emilie T., et al.
Publicado: (2018)

Divergent Connectivity Changes in Gray Matter Structural Covariance Networks in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer’s Disease
por: Fu, Zhenrong, et al.
Publicado: (2021)

Trajectories of subjective cognitive decline, and the risk of mild cognitive impairment and dementia
por: Liew, Tau Ming
Publicado: (2020)

Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer’s disease
por: Sohn, Dongwha, et al.
Publicado: (2018)

Factors Predicting the Onset of Amnestic Mild Cognitive Impairment or Alzheimer’s Dementia in Persons With Subjective Cognitive Decline
por: Ahn, Sangwoo, et al.
Publicado: (2020)

Memorability of photographs in subjective cognitive decline and mild cognitive impairment: Implications for cognitive assessment
por: Bainbridge, Wilma A., et al.
Publicado: (2019)

Editorial: Exploring Reliable Markers and Prediction Indexes for the Progression From Subjective Cognitive Decline to Cognitive Impairment
por: Jiang, Jiehui, et al.
Publicado: (2021)

Subjective cognitive decline, anxiety symptoms, and the risk of mild cognitive impairment and dementia
por: Liew, Tau Ming
Publicado: (2020)

Structural and Functional Abnormalities of Olfactory-Related Regions in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer’s Disease
por: Chen, Ben, et al.
Publicado: (2021)

Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment
por: Giacomucci, Giulia, et al.
Publicado: (2022)

Disproportionate Decline of Executive Functions in Early Mild Cognitive Impairment, Late Mild Cognitive Impairment, and Mild Alzheimer's Disease
por: Kim, Sangsoon, et al.
Publicado: (2016)

Blood Pressure in Different Dementia Disorders, Mild Cognitive Impairment, and Subjective Cognitive Decline
por: Hestad, Knut, et al.
Publicado: (2020)

Prediction of 7‐year's conversion from subjective cognitive decline to mild cognitive impairment
por: Yue, Ling, et al.
Publicado: (2020)

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
por: Xiong, Lisa Y., et al.
Publicado: (2021)

Association of Plasma Transferrin With Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer’s Disease
por: Guan, Jingjing, et al.
Publicado: (2020)

Editorial: Exploring reliable markers and prediction indexes for the progression from subjective cognitive decline to cognitive impairment, volume II
por: Jessen, Frank, et al.
Publicado: (2023)

Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer’s Disease continuum?
por: Lassi, Michael, et al.
Publicado: (2023)

Neurological Soft Signs in Aging, Mild Cognitive Impairment, and Alzheimer’s Disease – The Impact of Cognitive Decline and Cognitive Reserve
por: Urbanowitsch, Nadja, et al.
Publicado: (2015)

Abnormal organization of white matter networks in patients with subjective cognitive decline and mild cognitive impairment
por: Wang, Xiao-Ni, et al.
Publicado: (2016)

Subjective cognitive decline, APOE ε4, and incident mild cognitive impairment in men and women
por: Müller-Gerards, Diana, et al.
Publicado: (2019)

Psychosocial Effects of Corona Measures on Patients With Dementia, Mild Cognitive Impairment and Subjective Cognitive Decline
por: van Maurik, Ingrid S., et al.
Publicado: (2020)

Blood pressure in dementia, mild cognitive impairment, and subjective cognitive decline related to time of death
por: Hestad, Knut Asbjørn, et al.
Publicado: (2021)

Resting state EEG biomarkers of cognitive decline associated with Alzheimer’s disease and mild cognitive impairment
por: Meghdadi, Amir H., et al.
Publicado: (2021)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2023)

Specific EEG Changes Associated with Atrophy of Hippocampus in Subjects with Mild Cognitive Impairment and Alzheimer's Disease
por: Moretti, D. V., et al.
Publicado: (2012)

Hemoglobin A1c Serum Level Predicts 5-year Mortality in Patients with Cognitive Impairment
por: Dreier, J., et al.
Publicado: (2023)

The effect of statins on rate of cognitive decline in mild cognitive impairment
por: Smith, Kyle B., et al.
Publicado: (2017)

Gray and White Matter Changes in Subjective Cognitive Impairment, Amnestic Mild Cognitive Impairment and Alzheimer's Disease: A Voxel-Based Analysis Study
por: Kiuchi, Kuniaki, et al.
Publicado: (2014)

Longitudinal Changes in Performance on Cognitive Screening Tests in Patients with Mild Cognitive Impairment and Alzheimer Disease
por: Li, Fangzhou, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_odobptrinlid47gb1po3hmqtv5